Pretransplant Cardiac Evaluation Using Novel Technology
AbstractHematopoietic stem-cell transplantation (HSCT) is a complex procedure that has been increasingly successful in treating malignant and nonmalignant conditions. Despite its effectiveness, it can be associated with potentially life-threatening adverse effects. New onset heart failure, ischemic disease, and arrhythmias are among the most notable cardiovascular complications post-HSCT. As a result, appropriate cardiac risk stratification prior to transplant could result in decreased morbidity and mortality by identifying patients with a higher probability of tolerating possible toxicities associated with HSCT. In this review, we aim to discuss the utility of cardiac screening using novel modalities of imaging technology in the pre-HSCT phase. View Full-Text
Share & Cite This Article
Hemu, M.; Zimmerman, A.; Kalra, D.; Okwuosa, T. Pretransplant Cardiac Evaluation Using Novel Technology. J. Clin. Med. 2019, 8, 690.
Hemu M, Zimmerman A, Kalra D, Okwuosa T. Pretransplant Cardiac Evaluation Using Novel Technology. Journal of Clinical Medicine. 2019; 8(5):690.Chicago/Turabian Style
Hemu, Mohamad; Zimmerman, Allison; Kalra, Dinesh; Okwuosa, Tochukwu. 2019. "Pretransplant Cardiac Evaluation Using Novel Technology." J. Clin. Med. 8, no. 5: 690.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.